
ClearPoint Neuro CLPT
$ 13.28
-2.28%
Quarterly report 2025-Q3
added 11-06-2025
ClearPoint Neuro Operating Cycle 2011-2026 | CLPT
Annual Operating Cycle ClearPoint Neuro
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 266 | 349 | 415 | 336 | 372 | 344 | 377 | 338 | 299 | 429 | 1.78 K | 3.81 K | 623 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.81 K | 266 | 749 |
Quarterly Operating Cycle ClearPoint Neuro
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 223 | 200 | 228 | - | 252 | 289 | 267 | - | 375 | 349 | 436 | - | 524 | 339 | 312 | - | 273 | 333 | 254 | - | 376 | 438 | 328 | - | 335 | 325 | 295 | - | 410 | 387 | 404 | - | 357 | 308 | 41.3 | - | 48.9 | 71.6 | 68.2 | - | 89.2 | 135 | 76.2 | - | 67.6 | 36 | 68.7 | - | 75.8 | 125 | 43.9 | - | 35.9 | 37.5 | 39.4 | - | 31.7 | 50.7 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 524 | 31.7 | 222 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | ||
|
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M | ||
|
Cognyte Software Ltd.
CGNT
|
76.7 | $ 7.22 | - | $ 518 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
160 | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
299 | $ 3.91 | -1.69 % | $ 135 M | ||
|
Conformis
CFMS
|
216 | - | - | $ 16.4 M | ||
|
Alphatec Holdings
ATEC
|
351 | $ 13.54 | -2.59 % | $ 1.94 B | ||
|
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | ||
|
CONMED Corporation
CNMD
|
278 | $ 42.22 | -1.31 % | $ 1.3 B | ||
|
Bio-Rad Laboratories
BIO
|
304 | $ 294.76 | -1.65 % | $ 8.32 B | ||
|
Bruker Corporation
BRKR
|
274 | - | 1.76 % | $ 6.31 K | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
184 | - | -0.69 % | $ 108 B | ||
|
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | ||
|
Abbott Laboratories
ABT
|
183 | - | 0.72 % | $ 197 B | ||
|
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 5.0 | 8.7 % | $ 186 M | ||
|
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | ||
|
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
130 | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
InMode Ltd.
INMD
|
246 | $ 14.26 | -2.67 % | $ 1.13 B | ||
|
Eargo
EAR
|
156 | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
228 | - | - | $ 207 M | ||
|
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | ||
|
Pulmonx Corporation
LUNG
|
337 | $ 1.45 | -0.34 % | $ 56.7 M | ||
|
IRadimed Corporation
IRMD
|
308 | $ 103.26 | - | $ 1.31 B | ||
|
Integer Holdings Corporation
ITGR
|
120 | $ 86.35 | - | $ 2.9 B | ||
|
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
251 | $ 18.57 | -0.75 % | $ 122 M | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
343 | $ 88.28 | -0.37 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
265 | $ 11.05 | - | $ 851 M | ||
|
Establishment Labs Holdings
ESTA
|
634 | $ 72.06 | - | $ 2.03 B | ||
|
IRIDEX Corporation
IRIX
|
170 | $ 1.43 | - | $ 23.1 M | ||
|
Insulet Corporation
PODD
|
281 | $ 253.36 | 0.41 % | $ 17.8 B | ||
|
Invacare Corporation
IVC
|
289 | - | - | $ 24.7 M | ||
|
Medigus Ltd.
MDGS
|
411 | - | 10.28 % | $ 55.5 M | ||
|
Cytosorbents Corporation
CTSO
|
175 | $ 0.62 | -7.09 % | $ 33.7 M |